Nanobiotix reported asset growth of 9.48% for the quarter ended Dec 2025. These growth metrics cover 12 quarters of results from Dec 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2019 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||
| Assets Growth (1y) | 17.99% | 156.87% | -27.15% | -42.35% | -47.62% | -48.86% | 65.68% | 112.15% | -28.69% | -45.22% | 9.48% | |
| Assets Growth (3y) | 30.22% | -0.67% | -14.17% | -14.48% | -14.78% | -15.92% | 8.96% | |||||
| Assets Growth (5y) | 13.89% | 2.98% | -13.17% | |||||||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -5.99% | 265.72% | 320.79% | -32.42% | -45.43% | -56.02% | -64.98% | 91.82% | 203.30% | -34.38% | -54.34% | 15.53% |
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | 32.44% | 2.82% | -7.01% | -17.08% | -16.62% | -17.89% | -21.43% | 13.29% | ||||
| Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) | 14.41% | 6.47% | 2.18% | -15.44% | ||||||||
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 8.57% | -5.25% | -4.87% | -12.84% | -22.43% | -10.74% | -7.41% | -9.89% | -12.01% | -13.46% | -10.19% | |
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | -0.72% | -11.24% | -11.92% | -11.17% | -14.19% | -11.38% | -9.89% | |||||
| Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) | -6.81% | -10.65% | -11.60% | |||||||||
| Total Debt Growth (1y) | 115.67% | 25.83% | -5.53% | -20.45% | 1.63% | 21.34% | -7.45% | -18.69% | -0.03% | 10.46% | 102.95% | |
| Total Debt Growth (3y) | 36.86% | 6.50% | -3.86% | -7.76% | -2.03% | 2.91% | 23.37% | |||||
| Total Debt Growth (5y) | 19.25% | 2.25% | 12.51% |